Citations

Showing 10 of 108094 citations.

Meta-analysis of Treatment Outcomes of Non-saccular Aneurysms in the Posterior Circulation by Flow Diverters
Graffeo, Christopher S. , Perry, Avital , Rangel-Castilla, Leonardo , Brinjikji, Waleed , Kiyofuji, Satoshi , Murad, M. Hassan , Flemming, Kelly D. , Lanzino, Giuseppe , Rangel-Castilla, Leonardo

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | July 13, 2018 | Volume: 79 | Issue: S 01 | Pages: S1-S188

10.1055/s-0038-1633481 Get It

A Cross-sectional Survey of the North American Skull Base Society on Vestibular Schwannoma: Current Practice Patterns of Vestibular Schwannoma Evaluation and Management in North America
Carlson, Matthew L. , Wiet, Mark, Tombers, Nicole M. , Link, Michael J. , Gompel, Jamie J. Van , Devaiah, Anand K. , Lal, Devyani , Morcos, Jacques J.

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | July 13, 2018 | Volume: 79 | Issue: S 01 | Pages: S1-S188

10.1055/s-0038-1633440 Get It

Retractorless Surgery: Strokes, Edema, and Gliosis Outcomes Following Skull Base Surgery
Jackson, Christina , Ehresman, Jeffrey, Vivas-Buitrago, Tito , Quiñones‐Hinojosa, Alfredo , Chaichana, Kaisorn L. , Bettegowda, Chetan , Olivi, Alessandro

Mayo Clinic

Journal of Neurological Surgery Part B: Skull Base | July 13, 2018 | Volume: 79 | Issue: S 01 | Pages: S1-S188

10.1055/s-0038-1633350 Get It

Intraoperative Seizures in Awake Craniotomy for Perirolandic Glioma Resections That Undergo Cortical Mapping
Eseonu, Chikezie I. , Rincón-Torroella, Jordina , ReFaey, Karim , Tripathi, Punita, Quiñones‐Hinojosa, Alfredo , Lee, Young , ReFaey, Karim

Mayo Clinic

Journal of Neurological Surgery Part A: Central European Neurosurgery | July 13, 2018 | Volume: 79 | Issue: 03 | Pages: 239-246

10.1055/s-0037-1617759 | PMID 29346829 Get It

Background Perirolandic motor area gliomas present invasive eloquent region tumors within the precentral gyrus that are difficult to resect without causing neurologic deficits. Study Aims This study evaluates the role of awake craniotomy and motor mapping on neurologic outcome and extent of resection (EOR) of tumor in the perirolandic motor region. It also analyzes preoperative risk factors for intraoperative seizures. Methods We evaluated 57 patients who underwent an awake craniotomy for a perirolandic motor area eloquent region glioma. Patients who had positive mapping (PM) or intraoperative identification of motor regions in the cortex using direct cortical stimulation were compared with patients with no positive motor mapping following direct cortical stimulation and negative mapping (NM). Preoperative risks, intraoperative seizures, perioperative outcomes, tumor characteristics, and EOR were also compared. A logistic regression model was used to evaluate the predictors for intraoperative seizures in this patient cohort. Results Overall, 33 patients were in the PM cohort; 24 were in the NM cohort. Our study showed an 8.8% incidence of intraoperative seizures during cortical and subcortical mapping for awake craniotomies in the perirolandic motor area, none of which aborted the case. PM patients had significantly more intraoperative and postoperative seizures (15.5% and 30.3%, respectively) compared with the NM patients (0% and 8.3%, respectively; p = 0.046 and 0.044). New transient postoperative motor deficits were found more often in the PM group (51.5%) versus the NM group (12.5%; p = 0.002). A univariate logistic regression showed that PM (odds ratio [OR]: 1.16; 95% confidence interval [CI], 1.01–1.34; p = 0.035) and preoperative tumor volume (OR: 0.998; 95% CI, 0.996–0.999; p = 0.049) were significant predictors for intraoperative seizures in patients with perirolandic gliomas. Conclusion Awake craniotomies in the perirolandic motor region can be safely performed with a similar incidence of intraoperative seizures as reported for the language cortex. PM in this region may increase the likelihood of perioperative seizures or motor deficits compared with NM. Craniotomies that minimize cortical exposure for perirolandic gliomas that may not localize motor regions can still allow for extensive tumor resection with a good postoperative outcome.
Minimally Invasive Resection of Deep-seated High-grade Gliomas Using Tubular Retractors and Exoscopic Visualization
Iyer, Rajiv R. , Chaichana, Kaisorn L.

Mayo Clinic

Journal of Neurological Surgery Part A: Central European Neurosurgery | July 13, 2018 | Volume: 79 | Issue: 04 | Pages: 330-336

10.1055/s-0038-1641738 | PMID 29684925 Get It

Background and Study Aims/Objective Deep-seated high-grade gliomas (HGGs) represent a unique surgical challenge because they reside deep to critical cortical and subcortical structures and infiltrate functional areas of the brain. Therefore, accessing and resecting these tumors can often be challenging and associated with significant morbidity. We describe the use of minimally invasive approaches to access deep-seated HGGs to achieve extensive resections while minimizing surgical morbidity. Materials and Methods All patients who underwent resection of a deep-seated intraparenchymal HGG with the use of a tubular retractor with exoscopic visualization from January 2016 to May 2017 were identified prospectively at a single institution. Variables evaluated included tumor location, pre- and postoperative neurologic function, extent of resection, and length of hospital stay. Results Overall, 14 patients underwent resection of an HGG (11 glioblastomas, 3 anaplastic astrocytomas) with a tubular retractor under exoscopic visualization. Seven tumors (50%) involved the thalamus, three (21%) the motor corticospinal tract, two (14%) the inferior frontal occipital fasciculus, one (7%) each the basal ganglia and optic pathway. The median preoperative Karnofsky Performance Score (KPS) was 70 (interquartile range: 55–80), where the major presenting symptom was motor weakness in seven (50%). The average plus or minus the standard error of the mean percentage resection was 97.0 ± 1.2%. The median hospital stay was 4 days (range: 2–7). At 1 month postoperatively, median postoperative KPS (within 30 days) was 87 (range: 77–90), where eight (57%) were improved, five (36%) were stable, and one (7%) was worse postoperatively. Conclusions Deep-seated HGGs can be accessed, visualized, and resected using tubular retractors and exoscopic visualization with minimal morbidity.
Intravenous Ketamine for Adolescents with Treatment-Resistant Depression: An Open-Label Study
Amatya, Palistha, Roback, Mark G. , Albott, C. Sophia , Schreiner, Mindy Westlund , Ren, Yanan , Eberly, Lynn E. , Carstedt, Patricia, Samikoglu, Ali, Gunlicks‐Stoessel, Meredith , Reigstad, Kristina , Horek, Nathan, Tye, Susannah J. , Lim, Kelvin O. , Klimes‐Dougan, Bonnie , Tye, Susannah, Eberly, Lynn E. , Lim, Kelvin O , Tye, Susannah J , Cullen, Kathryn Regan

Mayo Clinic

Journal of Child and Adolescent Psychopharmacology | July 13, 2018 | Volume: 28 | Issue: 7 | Pages: 437-444

10.1089/cap.2018.0030 | PMID 30004254 Get It

Chronic treatment with the mitochondrial peptide humanin prevents age-related myocardial fibrosis in mice
Qin, Qing , Mehta, Hemal H. , Navarrete, Gerardo, Brandhorst, Sebastian , Wan, Junxiang , Delrio, Silvia , Zhang, Xin , Lerman, Lilach O. , Cohen, Pinchas , Yen, Kelvin , Lerman, Amir , Cohen, Pinchas

Mayo Clinic

American Journal of Physiology-Heart and Circulatory Physiology | July 13, 2018 | Volume: 315 | Issue: 5 | Pages: H1127-H1136

10.1152/ajpheart.00685.2017 | PMID 30004252 Get It

Cardiac fibrosis is a biological process that increases with age and contributes to myocardial dysfunction. Humanin (HN) is an endogenous mitochondria-derived peptide that has cytoprotective effects and reduces oxidative stress. The present study aimed to test the hypothesis that chronic supplementation of exogenous HN in middle-aged mice could prevent and reverse cardiac fibrosis and apoptosis in the aging heart. Female C57BL/6N mice at 18 mo of age received 14-mo intraperitoneal injections of vehicle (old group; n = 6) or HN analog (HNG; 4 mg/kg 2 times/wk, old + HNG group, n = 8) and were euthanized at 32 mo of age. C57BL/6N female mice (young group, n = 5) at 5 mo of age were used as young controls. HNG treatment significantly increased the ratio of cardiomyocytes to fibroblasts in aging hearts, as shown by the percentage of each cell type in randomly chosen fields after immunofluorescence staining. Furthermore, the increased collagen deposition in aged hearts was significantly reduced after HNG treatment, as indicated by picrosirius red staining. HNG treatment also reduced in aging mice cardiac fibroblast proliferation (5′-bromo-2-deoxyuridine staining) and attenuated transforming growth factor-β1, fibroblast growth factor-2, and matrix metalloproteinase-2 expression (immunohistochemistry or real-time PCR). Myocardial apoptosis was inhibited in HNG-treated aged mice (TUNEL staining). To decipher the pathway involved in the attenuation of the myocardial fibrosis by HNG, Western blot analysis was done and showed that HNG upregulated the Akt/glycogen synthase kinase -3β pathway in aged mice. Exogenous HNG treatment attenuated myocardial fibrosis and apoptosis in aged mice. The results of the present study suggest a role for the mitochondria-derived peptide HN in the cardioprotection associated with aging. NEW & NOTEWORTHY Cardiac fibrosis is a biological process that increases with age and contributes to myocardial dysfunction. Humanin is an endogenous mitochondria-derived peptide that has cytoprotective effects and reduces oxidative stress. Here, we demonstrate, for the first time, that exogenous humanin treatment attenuated myocardial fibrosis and apoptosis in aging mice. We also detected upregulated Akt/glycogen synthase kinase-3β pathway in humanin analog-treated mice, which might be the mechanism involved in the cardioprotective effect of humanin analog in aging mice.
Effect of Home Enteral Nutrition on Diabetes and Its Management
Vallumsetla, Nishanth, Epp, Lisa , Hurt, Ryan T. , Mundi, Manpreet S.

Mayo Clinic

Nutrition in Clinical Practice | July 13, 2018 | Volume: 34 | Issue: 2 | Pages: 250-256

10.1002/ncp.10104 | PMID 30004594 Get It

AbstractBackgroundDiabetes mellitus (DM) is estimated to affect 9% of Americans and is associated with significant morbidity, mortality, and increased healthcare costs.MethodsA retrospective review of a home enteral nutrition (HEN) database of patients seen between March 1, 2004, and April 31, 2014, at our institution was conducted to identify HEN patients who had a diagnosis of DM or were diagnosed within the acute period (4 months) of starting HEN therapy.Results174 (3.7%) of 4682 patients in the HEN program had DM. HEN was provided through a gastrostomy tube in 82 patients and through a jejunostomy tube in 92 patients. At 3 months, data were available for 42 gastrostomy patients; 44% had a change in DM management, with 60% undergoing a change to insulin. Similarly, 34 patients with jejunostomy had data available, with 41% undergoing change in medication and 93% being changed to insulin therapy. For patients with available glycated hemogloblin values, at 3 months the gastrostomy patients noted a decrease of 0.5% (7.3% ± 1.1% to 6.8% ± 0.7%, not significant) and the jejunostomy patients noted a decrease of 0.4% (6.9% ± 0.9% to 6.5% ± 1.1%, P = .06). Conclusions: Overall, our results suggest that closer follow‐up and laboratory assessment are necessary for management of HEN patients with DM. In those with data available, glycemic control can be maintained in patients receiving HEN with appropriate adjustment of DM management and focus on ensuring that patients are not overfed.
Evaluation of Oritavancin Combinations with Rifampin, Gentamicin, or Linezolid against Prosthetic Joint Infection-Associated Methicillin-Resistant Staphylococcus aureus Biofilms by Time-Kill Assays
Karau, Melissa J. , Raval, Yash S. , Patel, Robin , Yan, Qun , Patel, Robin , Yan, Qun , Raval, Yash S.

Mayo Clinic

Antimicrobial Agents and Chemotherapy | July 13, 2018 | Volume: 62 | Issue: 10 | Pages: No page available

10.1128/aac.00943-18 | PMID 30012765 Get It

The antibiofilm activity of oritavancin in combination with rifampin, gentamicin, or linezolid was evaluated against 10 prosthetic joint infection (PJI)-related methicillin-resistant Staphylococcus aureus (MRSA) isolates by time-kill assays. Oritavancin combined with rifampin demonstrated statistically significant bacterial reductions compared with those of either antimicrobial alone for all 10 isolates ( P ≤ 0.001), with synergy being observed for 80% of the isolates.
Non-invasive visualization of tumor infiltrating lymphocytes in patients with metastatic melanoma undergoing immune checkpoint inhibitor therapy: a pilot study
Galli, Filippo , Nevala, Wendy K. , Paulsen, Andrew, Hung, Joseph C., Gansen, Denise N. , Marchetti, Paolo , Wiseman, Gregory A., Signore, Alberto , Paulsen, Andrew M, Markovic, Svetomir N. , Suman, Vera J. , Erickson, Lori A.

Mayo Clinic

Oncotarget | July 13, 2018 | Volume: 9 | Issue: 54 | Pages: 30268-30278

10.18632/oncotarget.25666 | PMID 30100988 Get It